2018-2022年某三甲医院门诊血液透析感染事件监测

Surveillance of infections among hemodialysis patients in outpatient department of a three-A hospital from 2018 to 2022

  • 摘要:
    目的 了解血液透析患者感染的流行病学现状,为血液透析患者的感染预防与控制提供依据。
    方法 选择2018-2022年郑州大学第五附属医院血液净化室每个月前两个工作日维持血液透析患者为调查对象,前瞻性调查血液透析患者血液透析事件(包括静脉使用抗菌药物、血培养阳性和血管通路部位出现脓、红或肿胀加剧)发生情况。
    结果 2018-2022年共监测血透事件386例次(包括血流感染20例次,静脉使用抗菌药物354例次,血管通路部位出现脓、红或肿胀加剧12例次)。血液透析事件发生率为4.19/(100患者·月),血流感染平均发生率为0.22/(100患者·月),隧道式中心静脉导管患者发生血流感染风险是内瘘患者的40.69倍(95%CI:9.725~361.703,P<0.001),2022年血液透析患者血流感染发生率较2018年下降53.85%。金黄色葡萄球菌是引起血流感染的主要病原菌。
    结论 血液透析患者是感染的高风险人群,隧道式中心静脉导管患者血流感染和其他感染的发生率高于其他类型血管通路患者,开展血液透析感染事件监测可以降低血液透析患者血流感染发生率。

     

    Abstract:
    OBJECTIVE To investigate the epidemiological characteristics of infections in hemodialysis patients so as to provide bases for prevention and control of the infections in the hemodialysis patients.
    METHODS The patients who underwent maintenance hemodialysis in blood purification rooms of the Fifth Affiliated Hospital of Zhengzhou University in the first two working days each month from 2018 to 2022 were recruited as the research subjects. The incidence of hemodialysis-related events among the hemodialysis patients, including intravenous use of antibiotics, positive blood culture, exacerbation of pus, redness or swellings emerging at vascular access sites, were prospectively investigated.
    RESULTS A total of 386 case-times of hemodialysis-related events were monitored in 2018-2022, including 20 case-times of bloodstream infections, 354 case-times of intravenous use of antibiotics and 12 case-times of exacerbation of pus, redness or swellings emerging at vascular access sites. The incidence of hemodialysis-induced events was 4.19 per 100 patients each month, the average incidence rate of bloodstream infections was 0.22 per 100 patients each month. The patients with tunneled central venous catheter were 40.69 times the risk of bloodstream infections as the patients with intestinal fistula (95%CI: 9.725~361.703, P < 0.001). The incidence of bloodstream infections was decreased by 53.85% among the hemodialysis patients in 2022 as compared with that in 2018. Staphylococcus aureus was the predominant species of pathogens causing the bloodstream infections.
    CONCLUSIONS The hemodialysis patients are the population at high risk of infections. The incidence of bloodstream infections and other infections is higher among the patients with tunneled central venous catheters than among the patients with other types of vascular accesses. The monitoring of hemodialysis-related infection events may reduce the incidence of bloodstream infections.

     

/

返回文章
返回